Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes

Autism spectrum disorders (ASDs) are genetically and clinically heterogeneous and lack effective medications to treat their core symptoms. Studies of syndromic ASDs caused by single gene mutations have provided insights into the pathophysiology of autism. Fragile X and Rett syndromes belong to the...

Full description

Bibliographic Details
Main Authors: Hansen eWang, Sandipan ePati, Lucas ePozzo-Miller, Laurie eDoering
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-02-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Dopamine
Fragile X Syndrome
Minocycline
Oxytocin
Pharmacology
Rett Syndrome
Online Access:http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00055/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00055/full

Similar Items